The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-'The best shield': Peru launches inoculation drive with Sinopharm vaccine

Wed, 10th Feb 2021 01:13

(Adds comment from Peru's president)

By Marco Aquino

LIMA, Feb 9 (Reuters) - Peru launched its COVID-19
vaccination campaign on Tuesday with newly arrived doses of
China's Sinopharm vaccine, as the South American
country struggles to control a fierce second wave of infections
that has forced a lockdown in the capital, Lima.

Health officials kicked off the program in the intensive
care unit of Lima's Arzobispo Loayza Hospital, authorities said,
where medical staff were slated to receive the first of 300,000
doses delivered on Sunday by Sinopharm Group Co Ltd.

Peruvian President Francisco Sagasti was vaccinated later in
the day and urged vaccine skeptics to get inoculated. A survey
by Ipsos Peru last month showed 48% of Peruvians would refuse to
be vaccinated, citing fears of side effects.

"Do not be afraid of the vaccine. The vaccine is the best
shield," Sagasti said in a brief speech shortly before receiving
his shot at a military hospital.

"We are betting as much as possible that all Peruvians can
be vaccinated this year," he added.

Coronavirus infections have spiked in Peru this year,
bringing hospitals and the country's ailing healthcare system to
the brink of collapse. Authorities have detected both the
Brazilian and British variants of the virus, officials said.

Peru, which was mired in a political crisis last year,
initially lagged behind its wealthier neighbors in locking down
COVID-19 vaccine deals.

The Andean nation has since signed agreements with
U.S.-based Pfizer Inc, British-Swedish firm AstraZeneca
and Sinopharm, and is also slated to receive vaccines
through the World Health Organization's COVAX program.

The country plans to begin immediately inoculating a
million health officials, police and military personnel, among
others, the government said, in a first round of vaccinations
that will likely run through March.

Peru will then vaccinate 5.3 million elderly people, those
suffering from pre-existing conditions and its native
communities.

Peru's deal with Sinopharm guarantees the country 38 million
doses. A fresh batch of 700,000 doses is expected to arrive on
Sunday, health officials said.

Peru has tallied almost 1.2 million cases of COVID-19 and
42,400 deaths.
(Reporting by Marco Aquino and Reuters TV; Writing by Dave
Sherwood; Editing by Paul Simao and Peter Cooney)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.